FDA.reportPublic FDA data

SITagliptin phosphate 50 MG Oral Tablet

RxCUI
2709608
RxNorm name
SITagliptin phosphate 50 MG Oral Tablet
Display name
SITagliptin phosphate 50 MG Oral Tablet
Full name
SITagliptin phosphate 50 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JANUVIASITAGLIPTINA-S Medication Solutions194c3718-5eb5-4cf5-85d0-2bb1ed8293b82026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 2709608
JANUVIASITAGLIPTINA-S Medication Solutionseb81a45f-05b8-49de-99ce-5089bd360d9b2026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 2709608
Sitagliptin PhosphateSITAGLIPTIN PHOSPHATESandoz Inccebc8388-c9db-4e27-8d6b-0d9bdc9d766d2026-05-10Warnings, Adverse reactionsExact identifier
rxcui: 2709608
SitagliptinSITAGLIPTINApotex Corp.983e9e14-e9bd-3136-e573-98b4dc67860b2026-04-14Warnings, Adverse reactionsExact identifier
rxcui: 2709608
SitagliptinSITAGLIPTINTeva Pharmaceuticals, Inc.5fa5aa67-455e-4ac6-864d-268a912864322025-12-01Warnings, Adverse reactionsExact identifier
rxcui: 2709608
JANUVIASITAGLIPTINCardinal Health 107, LLC39253ddd-0245-43b1-ad28-d5923983afb42025-11-05Warnings, Adverse reactionsExact identifier
rxcui: 2709608
JANUVIASITAGLIPTINMerck Sharp & Dohme LLCf85a48d0-0407-4c50-b0fa-7673a160bf012024-11-14Warnings, Adverse reactionsExact identifier
rxcui: 2709608

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f85a48d0-0407-4c50-b0fa-7673a160bf01SITagliptin phosphate 50 MG Oral Tablet [PSN] · sitagliptin phosphate 50 MG Oral Tablet [SCD]271These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620241114
39253ddd-0245-43b1-ad28-d5923983afb4SITagliptin phosphate 50 MG Oral Tablet [PSN] · sitagliptin phosphate 50 MG Oral Tablet [SCD]226These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620251105
194c3718-5eb5-4cf5-85d0-2bb1ed8293b8SITagliptin phosphate 50 MG Oral Tablet [PSN] · sitagliptin phosphate 50 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230827
eb81a45f-05b8-49de-99ce-5089bd360d9bSITagliptin phosphate 50 MG Oral Tablet [PSN] · sitagliptin phosphate 50 MG Oral Tablet [SCD]28These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620230616
aaadccea-4842-493b-a0bd-0ee7645fc250SITagliptin phosphate 50 MG Oral Tablet [PSN] · sitagliptin phosphate 50 MG Oral Tablet [SCD]23These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initial U.S. Approval: 200620100521
983e9e14-e9bd-3136-e573-98b4dc67860bSITagliptin phosphate 50 MG Oral Tablet [PSN] · sitagliptin phosphate 50 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use SITAGLIPTIN TABLETS safely and effectively. See full prescribing information for SITAGLIPTIN TABLETS . SITAGLIPTIN tablets, for oral use Initial U.S. Approval: 200620260414